Triptodur Approval History
Triptodur (triptorelin) is a gonadotropin releasing hormone (GnRH) agonist indicated for the treatment of pediatric patients with central precocious puberty.
Development History and FDA Approval Process for Triptodur
|Jun 30, 2017||Arbor Pharmaceuticals, LLC Announces FDA Approval for Triptodur (triptorelin)|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.